Skip to main content
Caplight Logo









Molecule Mind

Molecule Mind

Private
BeijingHealthcare & Life Scienceshttps://moleculemind.com/

Last Round

Series A

Sep 13, 2024

Total Funding Raised

$114.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Molecule Mind is a biotechnology company that develops an AI-driven platform for protein prediction, optimization, and design.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Revenue Share

AI Layer

Application

Keywords

drug discoveryprotein engineeringAI drug discoveryin silico drug discoverygenerative biologyantibody discoverypredictive modelingcontract research organizationCROGPCR ligand modelingvirtual screeningde novo protein designbiotech softwareAI-native biotechdrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Molecule Mind Comparables

Compare Molecule Mind with similar companies based on industry and business-model similarity.

Molecule Mind comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chai Discovery
84%
Insilico Medicine
79%
EvolutionaryScale
79%

Molecule Mind Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 13, 2024
Series AJan 21, 2024
StrategicFeb 20, 2023
AngelApr 18, 2022

Molecule Mind Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Grew 24% QoQ from 21 to 26 employees.

  • Jul 24, 2026

    Monthly visitors grew 183% MoM, reaching 3.1K.

Molecule Mind Filings

Explore SEC and related filing metadata, where available.

Molecule Mind filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Molecule Mind's valuation, stock price, and market status.

Is Molecule Mind a public or private company?

Molecule Mind is a private company.

What is the current stock price of Molecule Mind?

Molecule Mind is a private company with no public stock price. No recent secondary market data is available.

How much is Molecule Mind worth (valuation)?

Valuation information for Molecule Mind is not publicly available.

Can I buy Molecule Mind stock?

Molecule Mind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Molecule Mind's last funding round?

Funding round information for Molecule Mind is not publicly available.

Who are the main investors in Molecule Mind?

Investor information for Molecule Mind is not publicly disclosed.

Will Molecule Mind IPO soon?

No public IPO plans have been announced for Molecule Mind.

How can I track Molecule Mind secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Molecule Mind's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range25
Year Founded2022
Last FundingSep 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?